We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELVN icon
13601
CALL
Enliven Therapeutics
ELVN
$4.3B
$3.57K ﹤0.01%
175
-2,350
-93% -$47.5K
XRAY icon
13602
Dentsply Sirona
XRAY
$2.33B
$3.56K ﹤0.01%
89
-720,444
-100% -$28.6M
EVCM icon
13603
PUT
EverCommerce
EVCM
$1.77B
$3.55K ﹤0.01%
300
+100
+50% +$1.17K
BMRC icon
13604
CALL
Bank of Marin Bancorp
BMRC
$457M
$3.53K ﹤0.01%
+200
New +$3.63K
CVIIW
13605
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$3.52K ﹤0.01%
25,133
-1,420
-5% -$173
ATLO icon
13606
AMES National
ATLO
$280M
$3.5K ﹤0.01%
+194
New +$3.65K
CAMP
13607
CALL
DELISTED
CalAmp Corp.
CAMP
$3.5K ﹤0.01%
143
-87
-38% -$4.22K
BYFC icon
13608
CALL
Broadway Financial
BYFC
$110M
$3.49K ﹤0.01%
450
-550
-55% -$4.31K
WMC
13609
PUT
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$3.46K ﹤0.01%
+390
New +$3.39K
GALT icon
13610
PUT
Galectin Therapeutics
GALT
$353M
$3.46K ﹤0.01%
2,400
-900
-27% -$1.53K
QNTM
13611
PUT
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$23.6M
$3.45K ﹤0.01%
46
-28
-38% -$2.4K
AQUNR
13612
DELISTED
Aquaron Acquisition Corp. Rights
AQUNR
$3.44K ﹤0.01%
+19,108
New +$5.74K
BRY
13613
PUT
DELISTED
Berry Corp
BRY
$3.44K ﹤0.01%
500
-33,700
-99% -$243K
ABST
13614
PUT
DELISTED
Absolute Software Corp
ABST
$3.44K ﹤0.01%
300
-1,000
-77% -$10K
SPRU icon
13615
PUT
Spruce Power Holding Corp
SPRU
$34.5M
$3.41K ﹤0.01%
525
-2,000
-79% -$12.5K
KPTI icon
13616
CALL
Karyopharm Therapeutics
KPTI
$45.6M
$3.4K ﹤0.01%
127
-1,086
-90% -$46.8K
IBCP icon
13617
PUT
Independent Bank Corp
IBCP
$847M
$3.39K ﹤0.01%
200
-800
-80% -$13.7K
SOGP
13618
PUT
Sound Group
SOGP
$47.2M
$3.37K ﹤0.01%
370
-110
-23% -$870
IGC icon
13619
CALL
IGC Pharma
IGC
$30.9M
$3.37K ﹤0.01%
10,800
INVE icon
13620
PUT
Identive
INVE
$64.1M
$3.36K ﹤0.01%
400
+100
+33% +$682
DPRO
13621
Draganfly
DPRO
$178M
$3.34K ﹤0.01%
+104
New +$2.68K
AIA icon
13622
iShares Asia 50 ETF
AIA
$5.05B
$3.34K ﹤0.01%
56
-29,294
-100% -$1.75M
WATT icon
13623
PUT
Energous
WATT
$83.5M
$3.34K ﹤0.01%
23
-1
-4% -$214
NAGE
13624
PUT
Niagen Bioscience
NAGE
$239M
$3.3K ﹤0.01%
2,100
-900
-30% -$1.34K
NFBK
13625
CALL
DELISTED
Northfield Bancorp
NFBK
$3.29K ﹤0.01%
300
-100
-25% -$1.07K

Similar funds

Citadel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.

  • Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Citadel Advisors opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.